Tocilizumab OverviewTocilizumab (INN, trade name Actemra), also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myelo...
Read more Tocilizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tocilizumab
Recent Tocilizumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 162mg/0.9ml, 200mg/10ml, 400mg/20ml, 80mg/4ml
NDC Database Records for Tocilizumab: (1 result)Sorted by National Drug Code
- 50242-143 Actemra Actpen 180 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.